Eli Lilly & Co. (LLY) News and Global Pharmaceutical Innovation Updates

1,123.54
44.76
4.15 %
Daily range
Weekly range
  • Jainam Mehta
  • 9 hours ago
Eli Lilly stock price forecast: $1,155.70 resistance as LLY advances 4.39%
Eli Lilly and Company (LLY) stock is trading at $1,128.52, having risen 4.39% on the day. The price currently sits above its key moving averages, highlighting positive ...
  • Ciaran Ryan
  • 02.06.2026
GE Vernova fails to end Vineyard Wind work mandate in Massachusetts dispute
A Massachusetts court keeps pressure on GE Vernova to stay on the Vineyard Wind project as the companies fight over payments and turbine support. The ruling preserves work on New England's largest ...
  • Jainam Mehta
  • 01.06.2026
Selling pressure pushes Eli Lilly stock lower in today's trading
Eli Lilly and Company (LLY) is trading at $1,077.25 and ended the day down 2.38%. The stock remains well above its 20-, 50-, and 200-day moving averages, confirming a robust uptrend across short, ...
  • Parshwa Turakhiya
  • 01.06.2026
LLY shares consolidate within recent $1,059–$1,132 range as buyers maintain control: weekly forecast
Eli Lilly and Company (LLY) is trading at $1,096.25, holding well above its weekly MA-20 at $991.40, MA-50 at $911.88, and MA-200 at $693.53. Over the last week, LLY ...
  • Andrey Mastykin
  • 29.05.2026
Eli Lilly stock price forecast: $999.66 support in focus as LLY drops 3.05%
Eli Lilly and Company (LLY) stock is trading at $1,093.63, marking a daily decline of 3.05%. The price remains well above its key moving averages, reflecting resilience ...
  • Sholanke Dele
  • 29.05.2026
Why is Eli Lilly stock down today?
Eli Lilly and Company (LLY) is currently trading at $1,095.37, down $32.72 or 2.90% for the day. The stock remains well above its 20-day ($1,007.90), 50-day ($950.70), and 200-day ($935.10) moving ...
  • Sholanke Dele
  • 28.05.2026
Eli Lilly shares jump as stock buying pressure builds
Eli Lilly and Company (LLY) is trading at $1,129.15, advancing $46.23 or 4.27% today. The stock remains significantly above its 20-day ($994.04), 50-day ($946.74), and 200-day ($932.63) moving ...
  • Dmytro Kharkov
  • 28.05.2026
Eli Lilly stock price forecast: $1,170 resistance as LLY gains 5.49%
Eli Lilly and Company (LLY) stock is trading at $1,142.36, up 5.49% on the day, and remains well above its key moving averages, reflecting strong upward ...
  • Ashutosh Sureka
  • 27.05.2026
Buying pressure lifts Eli Lilly stock higher in today's trading
Eli Lilly and Company (LLY) is currently trading at $1,086.93, up 2.08% on the day. The stock is positioned well above its MA-20 ($983.65), MA-50 ($944.89), and MA-200 ($930.35), highlighting ...
  • Sholanke Dele
  • 25.05.2026
Eli Lilly shares advance supported by robust institutional buying: weekly report
Eli Lilly and Company (LLY) is currently trading at $1,065.40, representing an impressive weekly gain of $62.31 or 6.21%. The stock sits significantly above its weekly ...
  • Igor Krasulya
  • 22.05.2026
Buying pressure lifts Eli Lilly stock higher in today's trading
Eli Lilly and Company (LLY) trades at $1,064.24 after rising $22.43, or 2.15% on the day, with intraday volatility at 1.05%. The stock is positioned well above the 20-day, 50-day, and 200-day ...
  • Dmytro Kharkov
  • 21.05.2026
What triggered Eli Lilly shares' latest price surge
Eli Lilly and Company (LLY) is trading at $1,042.63, rising by $23.63, or 2.32%, on the day. The stock trades well above its key 20-, 50-, and 200-day moving averages, affirming a robust bullish ...
  • Igor Krasulya
  • 19.05.2026
Eli Lilly stock price forecast: $1,050 resistance as LLY rallies 3.25% to $1,021.31
Eli Lilly and Company (LLY) is trading at $1,021.31, up 3.25% for the day and positioned well above its key moving ...
  • Ciaran Ryan
  • 19.05.2026
White House expands TrumpRx with generic drugs for U.S. prescription cost push
The Trump administration is broadening its direct-to-consumer prescription platform as it seeks to lower medicine costs for Americans. The update adds more than 600 generic drugs and new pharmacy ...
  • Jainam Mehta
  • 18.05.2026
LLY stock slides slightly as price stalls near the MA-20 resistance: weekly outlook
Eli Lilly and Company (LLY) closed the week at $986.51, declining $16.58 or 1.77% over the last 7 days. The price remains just below the weekly MA-20 at $990.14, while ...
  • Andrey Mastykin
  • 13.05.2026
Eli Lilly stock advances as Lormalzi (donanemab) launch in India boosts sentiment
Eli Lilly and Company (LLY) is trading at $1,019.57, having gained 3.08% on the session. The price sits well above its key moving averages, reflecting persistent ...
  • Dmytro Kharkov
  • 11.05.2026
Eli Lilly stock rises as Orforglipron completes Phase 3 weight loss trial
Eli Lilly and Company (LLY) is trading at $987.05, up 4.06% today. The price currently sits above its key moving averages, reflecting strong short-term and long-term ...
  • Emilio Ghigini
  • 11.05.2026
LLY stock ticks up as MACD and Stochastic RSI signal caution near $1,025 resistance: weekly report
Eli Lilly and Company (LLY) is trading at $974.34, positioned below the weekly MA-20 ($993.87), but well above the MA-50 ($894.98) and MA-200 ($682.62). Over the past ...
  • Jainam Mehta
  • 01.05.2026
Raised guidance lifts Eli Lilly stock to fresh highs in strong session
Eli Lilly and Company (LLY) is trading at $974.39, up 4.54% on the day. The asset remains above its key moving averages, highlighting continued strength and holding near ...
  • Sholanke Dele
  • 30.04.2026
LLY shares rise amid oversold momentum signals on technical chart: weekly report
Eli Lilly and Company (LLY) finished the week at $919.61, having gained $35.13, or 4.02%, and closed at the very top of its recent weekly range. The stock is trading ...
  • Jainam Mehta
  • 29.04.2026
What triggered Eli Lilly shares' latest price pullback
Eli Lilly and Company (LLY) is trading at $852.88 after falling 2.39% on the day. The stock remains sharply below its 20-day ($919.62), 50-day ($954.26), and 200-day ($909.37) moving averages, ...